Intuitive Surgical, Inc. $ISRG Holdings Lifted by Penobscot Investment Management Company Inc.

Penobscot Investment Management Company Inc. boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 146.7% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,325 shares of the medical equipment provider’s stock after buying an additional 4,356 shares during the quarter. Penobscot Investment Management Company Inc.’s holdings in Intuitive Surgical were worth $3,981,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Chilton Capital Management LLC boosted its position in shares of Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the period. Elite Financial Inc. acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at $26,000. LFA Lugano Financial Advisors SA acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at $30,000. TD Capital Management LLC boosted its position in shares of Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the period. Finally, 1248 Management LLC acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 2.1%

NASDAQ ISRG opened at $452.35 on Friday. The stock has a market capitalization of $162.16 billion, a PE ratio of 63.09, a price-to-earnings-growth ratio of 4.64 and a beta of 1.61. The company has a 50 day moving average price of $463.55 and a two-hundred day moving average price of $500.00. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company’s revenue was up 21.4% compared to the same quarter last year. During the same period in the previous year, the company earned $1.78 earnings per share. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 over the last ninety days. 0.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Piper Sandler restated an “overweight” rating and set a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Evercore ISI raised their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 8th. BTIG Research restated a “buy” rating and set a $571.00 price objective on shares of Intuitive Surgical in a research report on Wednesday. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Saturday, September 27th. Fourteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $594.19.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.